📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials (2025)

First Author: Rekowski J

Attributed to: MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2024.102987

Publication URI: http://dx.doi.org/10.1016/j.eclinm.2024.102987

Type: Journal Article/Review

Parent Publication: eClinicalMedicine